Target intelligence / Profile preview

Skin antigen-presenting cell (Skin APC) (Skin APC)

Target
Skin APC
Molecular classification
Other
01

Overview

Skin antigen-presenting cells (APCs) are a heterogeneous population of immune cells, including epidermal Langerhans cells and dermal dendritic cells, that serve as the primary sentinels of the cutaneous immune system. Their main biological role is to capture antigens from the environment or damaged tissue, process them, and migrate to skin-draining lymph nodes to present these antigens to naive T cells, thereby initiating adaptive immune responses or maintaining self-tolerance (Nestle et al., 2009, Nature Reviews Immunology). In various pathologies, such as psoriasis or atopic dermatitis, these cells can become overactive, driving chronic inflammation through the secretion of pro-inflammatory cytokines and the activation of pathogenic T-cell subsets (Kissenpfennig & Guilliams, 2010, Expert Reviews in Molecular Medicine). Conversely, in the context of skin cancer, their function may be suppressed, allowing for immune evasion by the tumor. Therapeutic interventions targeting skin APCs include topical corticosteroids and calcineurin inhibitors to reduce their activation in inflammatory diseases, as well as the use of adjuvants in intradermal vaccines to enhance their ability to stimulate protective immunity (Kim et al., 2012, Current Topics in Microbiology and Immunology). Because "Skin antigen-presenting cells" refers to a broad cell population rather than a single protein, it is considered a cellular target rather than a specific molecular target.

Other names
Cutaneous antigen-presenting cellSkin APCLangerhans cellDermal dendritic cell
02

Mechanism of action

Modulation of antigen uptake, processing, and presentation; inhibition of pro-inflammatory cytokine production; and regulation of immune cell migration to regional lymph nodes.

03

Biological functions

Antigen processingAntigen presentationImmune surveillanceT-cell activationTolerance inductionImmune response
04

Disease associations

InflammationCancerInfectionPsoriasisAtopic dermatitisOther
05

Safety considerations

Skin atrophyIncreased risk of local infectionSystemic immunosuppressionDelayed wound healingContact hypersensitivity
06

Interacting drugs

Clobetasol

4 more in the full profile.

07

Biomarkers

CD1aCD207 (Langerin)HLA-DRCD11cCD80CD86

Beyond the preview

Go deeper on Skin antigen-presenting cell (Skin APC) (Skin APC).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Skin antigen-presenting cell (Skin APC) (Skin APC).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call